Pancreatic Cancer Research

ResearcherTexas Tech UniversityNo recent work listed

Sanjay Srivastava

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8989-0438; OpenAlex author ID A5022942037; NIH RePORTER profile ID 2281255. Sources: OpenAlex.

Their work

Papers
6 (first author 3, last author 3)
Trials
0
Grants
1
Labs led
1
Collaborators
5
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: 1 paper, 1 grant · 2014: none · 2015: 1 paper · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: 1 paper · 2021: 1 paper

Papers 6

  1. Pimavanserin: A Novel Autophagy Modulator for Pancreatic Cancer Treatment. Last author DOI 10.3390/cancers13225661↗
  2. Repurposing Pimavanserin, an Anti-Parkinson Drug for Pancreatic Cancer Therapy. First author DOI 10.1016/j.omto.2020.08.019↗
  3. Penfluridol induces endoplasmic reticulum stress leading to autophagy in pancreatic cancer. Last author DOI 10.1177/1010428317705517↗
  4. STAT3 induces anoikis resistance, promotes cell invasion and metastatic potential in pancreatic cancer cells. First author DOI 10.1093/carcin/bgu233↗
  5. Pancreatic cancer chemoprevention by phytochemicals. First author DOI 10.1016/j.canlet.2012.10.020↗
  6. Role of mitochondrial electron transport chain complexes in capsaicin mediated oxidative stress leading to apoptosis in pancreatic cancer cells. Last author DOI 10.1371/journal.pone.0020151↗

Grants 1

  1. Chemoprevention of Pancreatic Cancer by Capsaicin R01CA129038↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Sharavan Ramachandran · 2 shared papers, 2020–2021 · strength 0.46
  2. Srinivas Reddy Boreddy · 2 shared papers, 2011–2013 · strength 0.12
  3. Neel Manoj Fofaria · 1 shared paper, 2015 · strength 0.11
  4. Alok Ranjan · 1 shared paper, 2017 · strength 0.09
  5. Kartick Chandra Pramanik · 1 shared paper, 2011 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.